Axogen Inc AXGN
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
Trading Information
- Previous Close Price
- $40.26
- Day Range
- $39.10–39.85
- 52-Week Range
- $11.74–46.70
- Bid/Ask
- $39.18 / $39.27
- Shares Outstanding
- 53.18M
- Market Cap
- $2.09B
- Volume/Avg
- 420,831 / 1M
Key Statistics
- Price/Earnings (Normalized)
- 125.83
- Price/Sales
- 8.06
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically and economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, and several other countries.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Growth
- Total Number of Employees
- 622
- Website
- https://www.axogeninc.com
Valuation
|
Metric
|
AXGN
|
|---|---|
Price/Earnings (Normalized) | 125.83 |
Price/Book Value | 8.74 |
Price/Sales | 8.06 |
Price/Cash Flow | 63.61 |
Price/Earnings
AXGN
Financial Strength
|
Metric
|
AXGN
|
|---|---|
Quick Ratio | 4.99 |
Current Ratio | 7.10 |
Interest Coverage | −4.12 |
Quick Ratio
AXGN
Profitability
|
Metric
|
AXGN
|
|---|---|
Return on Assets (Normalized) | 8.61% |
Return on Equity (Normalized) | 13.65% |
Return on Invested Capital (Normalized) | 12.73% |
Return on Assets
AXGN
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| LOCK|^HT^v< | LOCK|kvZC& | $174B | |||
| Stryker Corp
SYK
| LOCK|ybx#KQd | LOCK|!S | $121B | |||
| Medtronic PLC
MDT
| LOCK|KPM^g@s | LOCK|hxX! | $105B | |||
| Boston Scientific Corp
BSX
| LOCK|#gH$>G | LOCK|$%Ht | $64B | |||
| Edwards Lifesciences Corp
EW
| LOCK|KW#>#Cq | LOCK|>cYW | $49B | |||
| DexCom Inc
DXCM
| LOCK|^<M%#JS | LOCK|hDG^Z | $29B | |||
| GE HealthCare Technologies Inc Common Stock
GEHC
| LOCK|<ZVglB | LOCK|TNj | $28B | |||
| Koninklijke Philips NV ADR
PHG
| LOCK|SR | LOCK|!b | $26B | |||
| Steris PLC
STE
| LOCK|lW>^#<R | LOCK|$ZDkz | $21B | |||
| Zimmer Biomet Holdings Inc
ZBH
| LOCK|Yt%??QMc | LOCK|bgr | $17B |
United States